Sixonine Ventures

Sixonine Ventures is a life sciences venture capital and incubation firm that specializes in the creation and development of early-stage biotechnology companies. The firm utilizes a systematic approach to drug discovery and repositioning, often leveraging advanced computational platforms to identify novel therapeutic opportunities from existing pharmacological data. Founded by the leadership team behind Biovista, Sixonine Ventures provides the strategic framework, operational support, and initial capital necessary to transform high-potential scientific concepts into viable commercial entities. Its portfolio typically focuses on areas where data-driven insights can significantly reduce development risk and time-to-market for new therapies. The firm operates at the intersection of data science and drug development, bridging the gap between academic research and clinical-stage assets.